|
1
|
Panisello-Rosello A, Lopez A, Folch-Puy E,
Carbonell T, Rolo A, Palmeira C, Adam R, Net M and Roselló-Catafau
J: Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury:
An update. World J Gastroenterol. 24:2984–2994. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu
J, Gao F, Wang S, Tan R and Yuan J: Ischemia-reperfusion injury:
Molecular mechanisms and therapeutic targets. Signal Transduct
Target Ther. 9:122024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bai X, Zhang J, Yang H, Linghu K and Xu M:
SNHG3/miR-330-5p/HSD11B1 alleviates myocardial ischemia-reperfusion
injury by regulating the ERK/p38 signaling pathway. Protein Pept
Lett. 30:699–708. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Y, Xiong Y, Luo J, Hu Q, Lan J, Zou
Y, Ma Q, Yao H, Liu Z, Zhong Z, et al: Aldehyde dehydrogenase 2
protects the kidney from Ischemia-reperfusion injury by suppressing
the I κ B α/NF-κ B/IL-17C pathway. Oxid Med Cell Longev.
2023:22640302023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Diao M, Xu J, Wang J, Zhang M, Wu C, Hu X,
Zhu Y, Zhang M and Hu W: Alda-1, an activator of ALDH2, improves
postresuscitation cardiac and neurological outcomes by inhibiting
pyroptosis in swine. Neurochem Res. 47:1097–1099. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao R, Lv C, Qu Y, Yang H, Hao C, Sun X,
Hu X, Yang Y and Tang Y: Remote ischemic conditioning mediates
cardio-protection after myocardial ischemia/reperfusion injury by
reducing 4-HNE levels and regulating autophagy via the
ALDH2/SIRT3/HIF1alpha signaling pathway. J Cardiovasc Transl Res.
17:169–182. 2024.PubMed/NCBI
|
|
7
|
Kang P, Wang J, Fang D, Fang T, Yu Y,
Zhang W, Shen L, Li Z, Wang H, Ye H and Gao Q: Activation of ALDH2
attenuates high glucose induced rat cardiomyocyte fibrosis and
necroptosis. Free Radic Biol Med. 146:198–210. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li M, Xu M, Li J, Chen L, Xu D, Tong Y,
Zhang J, Wu H, Kong X and Xia Q: Alda-1 ameliorates liver
Ischemia-Reperfusion injury by activating aldehyde dehydrogenase 2
and enhancing autophagy in mice. J Immunol Res. 2018:98071392018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin D, Xiang T, Qiu Q, Leung J, Xu J, Zhou
W, Hu Q, Lan J, Liu Z, Zhong Z, et al: Aldehyde dehydrogenase 2
regulates autophagy via the Akt-mTOR pathway to mitigate renal
ischemia-reperfusion injury in hypothermic machine perfusion. Life
Sci. 253:1177052020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin L, Tao JP, Li M, Peng J, Zhou C,
Ouyang J and Si YY: Mechanism of ALDH2 improves the neuronal damage
caused by hypoxia/reoxygenation. Eur Rev Med Pharmacol Sci.
26:2712–2720. 2022.PubMed/NCBI
|
|
11
|
Liu Z, Ye S, Zhong X, Wang W, Lai CH, Yang
W, Yue P, Luo J, Huang X, Zhong Z, et al: Pretreatment with the
ALDH2 activator Alda-1 protects rat livers from
ischemia/reperfusion injury by inducing autophagy. Mol Med Rep.
22:2373–2385. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma LL, Ding ZW, Yin PP, Wu J, Hu K, Sun
AJ, Zou YZ and Ge JB: Hypertrophic preconditioning cardioprotection
after myocardial ischaemia/reperfusion injury involves
ALDH2-dependent metabolism modulation. Redox Biol. 43:1019602021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan G, Roy B and Palaniyandi SS: Diabetic
aldehyde dehydrogenase 2 Mutant (ALDH2*2) mice are more susceptible
to cardiac Ischemic-Reperfusion injury due to 4-Hydroxy-2-Nonenal
induced coronary endothelial cell damage. J Am Heart Assoc.
10:e0211402021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Papatheodorou I, Galatou E, Panagiotidis
GD, Ravingerova T and Lazou A: Cardioprotective effects of
PPARbeta/delta activation against ischemia/reperfusion injury in
rat heart are associated with ALDH2 upregulation, amelioration of
oxidative stress and preservation of mitochondrial energy
production. Int J Mol Sci. 22:e0211402021. View Article : Google Scholar
|
|
15
|
Qu Y, Liu Y and Zhang H: ALDH2 activation
attenuates oxygen-glucose deprivation/reoxygenation-induced cell
apoptosis, pyroptosis, ferroptosis and autophagy. Clin Transl
Oncol. 25:3203–1326. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sidramagowda Patil S, Hernandez-Cuervo H,
Fukumoto J, Krishnamurthy S, Lin M, Alleyn M, Breitzig M, Narala
VR, Soundararajan R, Lockey RF, et al: Alda-1 attenuates
hyperoxia-induced acute lung injury in mice. Front Pharmacol.
11:5979422020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun X, Gao R, Li W, Zhao Y, Yang H, Chen
H, Jiang H, Dong Z, Hu J, Liu J, et al: Alda-1 treatment promotes
the therapeutic effect of mitochondrial transplantation for
myocardial ischemia-reperfusion injury. Bioact Mater. 6:2058–2069.
2021.PubMed/NCBI
|
|
18
|
Tan X, Chen YF, Zou SY, Wang WJ, Zhang NN,
Sun ZY, Xian W, Li XR, Tang B, Wang HJ, et al: ALDH2 attenuates
ischemia and reperfusion injury through regulation of mitochondrial
fusion and fission by PI3K/AKT/mTOR pathway in diabetic
cardiomyopathy. Free Radic Biol Med. 195:219–230. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu H, Xu S, Diao M, Wang J, Zhang G and Xu
J: Alda-1 treatment alleviates lung injury after cardiac arrest and
resuscitation in swine. Shock. 58:464–469. 2022.PubMed/NCBI
|
|
20
|
Xu T, Guo J, Wei M, Wang J, Yang K, Pan C,
Pang J, Xue L, Yuan Q, Xue M, et al: Aldehyde dehydrogenase 2
protects against acute kidney injury by regulating autophagy via
the Beclin-1 pathway. JCI Insight. 6:e1381832021.PubMed/NCBI
|
|
21
|
Yoval-Sanchez B, Calleja LF, de la Luz
Hernandez-Esquivel M and Rodriguez-Zavala JS: Piperlonguminine a
new mitochondrial aldehyde dehydrogenase activator protects the
heart from ischemia/reperfusion injury. Biochim Biophys Acta Gen
Subj. 1864:1296842020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu Q, Gao J, Shao X, Lu W, Chen L and Jin
L: The Effects of Alda-1 treatment on renal and intestinal injuries
after cardiopulmonary resuscitation in pigs. Front Med (Lausanne).
9:8924722022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang R, Xue MY, Liu BS, Wang WJ, Fan XH,
Zheng BY, Yuan QH, Xu F, Wang JL and Chen YG: Aldehyde
dehydrogenase 2 preserves mitochondrial morphology and attenuates
hypoxia/reoxygenation-induced cardiomyocyte injury. World J Emerg
Med. 11:246–254. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang ZX, Li H, He JS, Chu HJ, Zhang XT
and Yin L: Remote ischemic postconditioning alleviates myocardial
ischemia/reperfusion injury by up-regulating ALDH2. Eur Rev Med
Pharmacol Sci. 22:6475–6484. 2018.PubMed/NCBI
|
|
25
|
Zhou T, Wang X, Wang K, Lin Y, Meng Z, Lan
Q, Jiang Z, Chen J, Lin Y, Liu X, et al: Activation of aldehyde
dehydrogenase-2 improves ischemic random skin flap survival in
rats. Front Immunol. 14:11276102023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen CH, Ferreira JC, Gross ER and
Mochly-Rosen D: Targeting aldehyde dehydrogenase 2: New therapeutic
opportunities. Physiol Rev. 94:1–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lamb RJ, Griffiths K, Lip GYH, Sorokin V,
Frenneaux MP, Feelisch M and Madhani M: ALDH2 polymorphism and
myocardial infarction: From alcohol metabolism to redox regulation.
Pharmacol Ther. 259:1086662024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoshida A, Hsu LC and Yasunami M: Genetics
of human alcohol-metabolizing enzymes. Prog Nucleic Acid Res Mol
Biol. 40:255–287. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mali VR and Palaniyandi SS: Regulation and
therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart
disease. Free Radic Res. 48:251–263. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schneider C, Porter NA and Brash AR:
Routes to 4-hydroxynonenal: Fundamental issues in the mechanisms of
lipid peroxidation. J Biol Chem. 283:15539–15543. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kimura M, Yokoyama A and Higuchi S:
Aldehyde dehydrogenase-2 as a therapeutic target. Expert Opin Ther
Targets. 23:955–966. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ke K, Li L, Lu C, Zhu Q, Wang Y, Mou Y,
Wang H and Jin W: The crosstalk effect between ferrous and other
ions metabolism in ferroptosis for therapy of cancer. Front Oncol.
12:9160822022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fang X, Ardehali H, Min J and Wang F: The
molecular and metabolic landscape of iron and ferroptosis in
cardiovascular disease. Nat Rev Cardiol. 20:7–23. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiang Q, Yi X, Zhu XH, Wei X and Jiang DS:
Regulated cell death in myocardial ischemia-reperfusion injury.
Trends Endocrinol Metab. 35:219–234. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu L, Pang J, Qin D, Li R, Zou D, Chi K,
Wu W, Rui H, Yu H, Zhu W, et al: Deubiquitinase OTUD5 as a novel
protector against 4-HNE-triggered ferroptosis in myocardial
ischemia/reperfusion injury. Adv Sci (Weinh). 10:e23018522023.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bi Y, Liu S, Qin X, Abudureyimu M, Wang L,
Zou R, Ajoolabady A, Zhang W, Peng H, Ren J and Zhang Y: FUNDC1
interacts with GPx4 to govern hepatic ferroptosis and fibrotic
injury through a mitophagy-dependent manner. J Adv Res. 55:45–60.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu W, Feng D, Shi X, Wei Q and Yang L:
The potential role of mitochondrial acetaldehyde dehydrogenase 2 in
urological cancers from the perspective of ferroptosis and cellular
senescence. Front Cell Dev Biol. 10:8501452022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Droge W: Free radicals in the
physiological control of cell function. Physiol Rev. 82:47–95.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen CH, Sun L and Mochly-Rosen D:
Mitochondrial aldehyde dehydrogenase and cardiac diseases.
Cardiovasc Res. 88:51–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wilson DF and Matschinsky FM: Ethanol
metabolism: The good, the bad, and the ugly. Med Hypotheses.
140:1096382020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hink U, Daiber A, Kayhan N, Trischler J,
Kraatz C, Oelze M, Mollnau H, Wenzel P, Vahl CF, Ho KK, et al:
Oxidative inhibition of the mitochondrial aldehyde dehydrogenase
promotes nitroglycerin tolerance in human blood vessels. J Am Coll
Cardiol. 50:2226–2232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu Y, Yuan Q, Cao S, Cui S, Xue L, Song X,
Li Z, Xu R, Yuan Q and Li R: Aldehyde dehydrogenase 2 inhibited
oxidized LDL-induced NLRP3 inflammasome priming and activation via
attenuating oxidative stress. Biochem Biophys Res Commun.
529:998–1004. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Moldovan L and Moldovan NI: Oxygen free
radicals and redox biology of organelles. Histochem Cell Biol.
122:395–412. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bielski BH, Arudi RL and Sutherland MW: A
study of the reactivity of HO2/O2-with unsaturated fatty acids. J
Biol Chem. 258:4759–4761. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Browne RW and Armstrong D: HPLC analysis
of lipid-derived polyunsaturated fatty acid peroxidation products
in oxidatively modified human plasma. Clin Chem. 46:829–836. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Schneider C, Boeglin WE, Yin H, Porter NA
and Brash AR: Intermolecular peroxyl radical reactions during
autoxidation of hydroxy and hydroperoxy arachidonic acids generate
a novel series of epoxidized products. Chem Res Toxicol.
21:895–903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Singh S, Brocker C, Koppaka V, Chen Y,
Jackson BC, Matsumoto A, Thompson DC and Vasiliou V: Aldehyde
dehydrogenases in cellular responses to oxidative/electrophilic
stress. Free Radic Biol Med. 56:89–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gao J, Hao Y, Piao X and Gu X: Aldehyde
dehydrogenase 2 as a therapeutic target in oxidative stress-related
diseases: Post-translational modifications deserve more attention.
Int J Mol Sci. 23:26822022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Breitzig M, Bhimineni C, Lockey R and
Kolliputi N: 4-Hydroxy-2-nonenal: A critical target in oxidative
stress? Am J Physiol Cell Physiol. 311:C537–C543. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schaur RJ, Siems W, Bresgen N and Eckl PM:
4-Hydroxy-nonenal-a bioactive lipid peroxidation product.
Biomolecules. 5:2247–337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Forman HJ: Reactive oxygen species and
alpha, beta-unsaturated aldehydes as second messengers in signal
transduction. Ann N Y Acad Sci. 1203:35–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shoeb M, Ansari NH, Srivastava SK and
Ramana KV: 4-Hydroxynonenal in the pathogenesis and progression of
human diseases. Curr Med Chem. 21:230–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang H and Forman HJ: Signaling pathways
involved in phase II gene induction by alpha, beta-unsaturated
aldehydes. Toxicol Ind Health. 25:269–278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dalleau S, Baradat M, Gueraud F and Huc L:
Cell death and diseases related to oxidative stress:
4-hydroxynonenal (HNE) in the balance. Cell Death Differ.
20:1615–1630. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xue Z, Zhao K, Sun Z, Wu C, Yu B, Kong D
and Xu B: Isorhapontigenin ameliorates cerebral
ischemia/reperfusion injury via modulating Kinase
Cepsilon/Nrf2/HO-1 signaling pathway. Brain Behav. 11:e021432021.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang Y, Li B, Liu G, Han Q, Diao Y and Liu
J: Corilagin attenuates intestinal ischemia/reperfusion injury in
mice by inhibiting ferritinophagy-mediated ferroptosis through
disrupting NCOA4-ferritin interaction. Life Sci. 334:1221762023.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Endo J, Sano M, Katayama T, Hishiki T,
Shinmura K, Morizane S, Matsuhashi T, Katsumata Y, Zhang Y, Ito H,
et al: Metabolic remodeling induced by mitochondrial aldehyde
stress stimulates tolerance to oxidative stress in the heart. Circ
Res. 105:1118–1127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Esterbauer H, Schaur RJ and Zollner H:
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and
related aldehydes. Free Radic Biol Med. 11:81–128. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Giera M, Lingeman H and Niessen WM: Recent
advancements in the LC- and GC-Based analysis of malondialdehyde
(MDA): A brief overview. Chromatographia. 75:433–440. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Esterbauer H and Zollner H: Methods for
determination of aldehydic lipid peroxidation products. Free Radic
Biol Med. 7:197–203. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Shen Z, Zhang Y, Bu G and Fang L: Renal
denervation improves mitochondrial oxidative stress and cardiac
hypertrophy through inactivating SP1/BACH1-PACS2 signaling. Int
Immunopharmacol. 141:1127782024. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tsikas D: Assessment of lipid peroxidation
by measuring malondialdehyde (MDA) and relatives in biological
samples: Analytical and biological challenges. Anal Biochem.
524:13–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lankin VZ, Tikhaze AK and Melkumyants AM:
Malondialdehyde as an important key factor of molecular mechanisms
of vascular wall damage under heart diseases development. Int J Mol
Sci. 24:1282022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Busch CJ and Binder CJ: Malondialdehyde
epitopes as mediators of sterile inflammation. Biochim Biophys Acta
Mol Cell Biol Lipids. 1862:398–406. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Agadjanyan ZS, Dmitriev LF and Dugin SF: A
new role of phosphoglucose isomerase. Involvement of the glycolytic
enzyme in aldehyde metabolism. Biochemistry (Mosc). 70:1251–1255.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu H, Wu X, Luo J, Wang X, Guo H, Feng D,
Zhao L, Bai H, Song M, Liu X, et al: Pterostilbene attenuates
astrocytic inflammation and neuronal oxidative injury after
Ischemia-reperfusion by inhibiting NF-κB phosphorylation. Front
Immunol. 10:24082019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Qi D, Chen P, Bao H, Zhang L, Sun K, Song
S and Li T: Dimethyl fumarate protects against hepatic
ischemia-reperfusion injury by alleviating ferroptosis via the
NRF2/SLC7A11/HO-1 axis. Cell Cycle. 22:818–828. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang IC, Lin JH, Lee WS, Liu CH, Lin TY
and Yang KT: Baicalein and luteolin inhibit
ischemia/reperfusion-induced ferroptosis in rat cardiomyocytes. Int
J Cardiol. 375:74–86. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Cao Z, Qin H, Huang Y, Zhao Y, Chen Z, Hu
J and Gao Q: Crosstalk of pyroptosis, ferroptosis, and
mitochondrial aldehyde dehydrogenase 2-related mechanisms in
sepsis-induced lung injury in a mouse model. Bioengineered.
13:4810–4820. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yoval-Sanchez B and Rodriguez-Zavala JS:
Differences in susceptibility to inactivation of human aldehyde
dehydrogenases by lipid peroxidation byproducts. Chem Res Toxicol.
25:722–729. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang T, Zhao Q, Ye F, Huang CY, Chen WM
and Huang WQ: Alda-1, an ALDH2 activator, protects against hepatic
ischemia/reperfusion injury in rats via inhibition of oxidative
stress. Free Radic Res. 52:629–638. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ma XH, Liu JH, Liu CY, Sun WY, Duan WJ,
Wang G, Kurihara H, He RR, Li YF, Chen Y, et al: ALOX15-launched
PUFA-phospholipids peroxidation increases the susceptibility of
ferroptosis in ischemia-induced myocardial damage. Signal Transduct
Target Ther. 7:2882022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yan HF, Tuo QZ, Yin QZ and Lei P: The
pathological role of ferroptosis in ischemia/reperfusion-related
injury. Zool Res. 41:220–230. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wu X, Li Y, Zhang S and Zhou X:
Ferroptosis as a novel therapeutic target for cardiovascular
disease. Theranostics. 11:3052–3059. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kagan VE, Mao G, Qu F, Angeli JP, Doll S,
Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized
arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem
Biol. 13:81–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Liu J, Kang R and Tang D: Signaling
pathways and defense mechanisms of ferroptosis. FEBS J.
289:7038–7050. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Liu C, Li Z, Li B, Liu W, Zhang S, Qiu K
and Zhu W: Relationship between ferroptosis and mitophagy in
cardiac ischemia reperfusion injury: A mini-review. PeerJ.
11:e149522023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liang C, Zhang X, Yang M and Dong X:
Recent progress in ferroptosis inducers for cancer therapy. Adv
Mater. 31:e19041972019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yang WS, Kim KJ, Gaschler MM, Patel M,
Shchepinov MS and Stockwell BR: Peroxidation of polyunsaturated
fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci
USA. 113:E4966–E49675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Haeggstrom JZ and Funk CD: Lipoxygenase
and leukotriene pathways: Biochemistry, biology, and roles in
disease. Chem Rev. 111:5866–5898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Braughler JM, Duncan LA and Chase RL: The
involvement of iron in lipid peroxidation. Importance of ferric to
ferrous ratios in initiation. J Biol Chem. 261:10282–10289. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Matsuyama M, Nakatani T, Hase T, Kawahito
Y, Sano H, Kawamura M and Yoshimura R: The expression of
cyclooxygenases and lipoxygenases in renal ischemia-reperfusion
injury. Transplant Proc. 36:1939–1942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Jiang M, Jike Y, Liu K, Gan F, Zhang K,
Xie M, Zhang J, Chen C, Zou X, Jiang X, et al: Exosome-mediated
miR-144-3p promotes ferroptosis to inhibit osteosarcoma
proliferation, migration, and invasion through regulating ZEB1. Mol
Cancer. 22:1132023. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Yang R, Gao W, Wang Z, Jian H, Peng L, Yu
X, Xue P, Peng W, Li K and Zeng P: Polyphyllin I induced
ferroptosis to suppress the progression of hepatocellular carcinoma
through activation of the mitochondrial dysfunction via
Nrf2/HO-1/GPX4 axis. Phytomedicine. 122:1551352024. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chen X, Huang J, Yu C, Liu J, Gao W, Li J,
Song X, Zhou Z, Li C, Xie Y, et al: A noncanonical function of
EIF4E limits ALDH1B1 activity and increases susceptibility to
ferroptosis. Nat Commun. 13:63182022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Jang EJ, Jeong HO, Park D, Kim DH, Choi
YJ, Chung KW, Park MH, Yu BP and Chung HY: Src Tyrosine kinase
activation by 4-hydroxynonenal upregulates p38, ERK/AP-1 signaling
and COX-2 expression in YPEN-1 Cells. PLoS One. 10:e01292442015.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lee J and Hyun DH: The interplay between
intracellular iron homeostasis and neuroinflammation in
neurodegenerative diseases. Antioxidants (Basel). 12:9182023.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Miyamoto HD, Ikeda M, Ide T, Tadokoro T,
Furusawa S, Abe K, Ishimaru K, Enzan N, Sada M, Yamamoto T, et al:
Iron overload via heme degradation in the endoplasmic reticulum
triggers ferroptosis in myocardial ischemia-reperfusion injury.
JACC Basic Transl Sci. 7:800–819. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Ito J, Omiya S, Rusu MC, Ueda H, Murakawa
T, Tanada Y, Abe H, Nakahara K, Asahi M, Taneike M, et al: Iron
derived from autophagy-mediated ferritin degradation induces
cardiomyocyte death and heart failure in mice. Elife.
10:e621742021. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Tang LJ, Zhou YJ, Xiong XM, Li NS, Zhang
JJ, Luo XJ and Peng J: Ubiquitin-specific protease 7 promotes
ferroptosis via activation of the p53/TfR1 pathway in the rat
hearts after ischemia/reperfusion. Free Radic Biol Med.
162:339–352. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Masaldan S, Clatworthy SAS, Gamell C,
Meggyesy PM, Rigopoulos AT, Haupt S, Haupt Y, Denoyer D, Adlard PA,
Bush AI and Cater MA: Iron accumulation in senescent cells is
coupled with impaired ferritinophagy and inhibition of ferroptosis.
Redox Biol. 14:100–115. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Li W, Li W, Wang Y, Leng Y and Xia Z:
Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated
ferritinophagy during diabetes myocardial ischemia/reperfusion
injury. Cell Death Discov. 7:2672021. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Fan Z, Cai L, Wang S, Wang J and Chen B:
Baicalin prevents myocardial ischemia/reperfusion injury through
inhibiting ACSL4 mediated ferroptosis. Front Pharmacol.
12:6289882021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wu Y, Jiao H, Yue Y, He K, Jin Y, Zhang J,
Zhang J, Wei Y, Luo H, Hao Z, et al: Ubiquitin ligase E3 HUWE1/MULE
targets transferrin receptor for degradation and suppresses
ferroptosis in acute liver injury. Cell Death Differ. 29:1705–1718.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Bresgen N, Jaksch H, Lacher H,
Ohlenschlager I, Uchida K and Eckl PM: Iron-mediated oxidative
stress plays an essential role in ferritin-induced cell death. Free
Radic Biol Med. 48:1347–1357. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ma S, Sun L, Wu W, Wu J, Sun Z and Ren J:
USP22 Protects against myocardial Ischemia-Reperfusion Injury via
the SIRT1-p53/SLC7A11-dependent inhibition of Ferroptosis-induced
cardiomyocyte death. Front Physiol. 11:5513182020. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Alim I, Caulfield JT, Chen Y, Swarup V,
Geschwind DH, Ivanova E, Seravalli J, Ai Y, Sansing LH, Ste Marie
EJ, et al: Selenium drives a transcriptional adaptive program to
block ferroptosis and treat stroke. Cell. 177:1262–1279.e25. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Yao X, Sun K, Yu S, Luo J, Guo J, Lin J,
Wang G, Guo Z, Ye Y and Guo F: Chondrocyte ferroptosis contribute
to the progression of osteoarthritis. J Orthop Translat. 27:33–43.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zhang Q, Jia M, Wang Y, Wang Q and Wu J:
Cell death mechanisms in cerebral Ischemia-Reperfusion injury.
Neurochem Res. 47:3525–3542. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Kalogeris T, Baines CP, Krenz M and
Korthuis RJ: Cell biology of ischemia/reperfusion injury. Int Rev
Cell Mol Biol. 298:229–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Guo J, Tuo QZ and Lei P: Iron,
ferroptosis, and ischemic stroke. J Neurochem. 165:487–520. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Green DR and Llambi F: Cell death
signaling. Cold Spring Harb Perspect Biol. 7:a0060802015.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Pang Q, Zhao Y, Chen X, Zhao K, Zhai Q and
Tu F: Apigenin protects the brain against Ischemia/Reperfusion
injury via Caveolin-1/VEGF in vitro and in vivo. Oxid Med Cell
Longev. 2018:70172042018. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Liu J, Li J, Yang Y, Wang X, Zhang Z and
Zhang L: Neuronal apoptosis in cerebral ischemia/reperfusion area
following electrical stimulation of fastigial nucleus. Neural Regen
Res. 9:727–734. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Teijido O and Dejean L: Upregulation of
Bcl2 inhibits apoptosis-driven BAX insertion but favors BAX
relocalization in mitochondria. FEBS Lett. 584:3305–3310. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Andreka G, Vertesaljai M, Szantho G, Font
G, Piroth Z, Fontos G, Juhasz ED, Szekely L, Szelid Z, Turner MS,
et al: Remote ischaemic postconditioning protects the heart during
acute myocardial infarction in pigs. Hear. 93:749–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Galluzzi L, Vitale I, Aaronson SA, Abrams
JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews
DW, et al: Molecular mechanisms of cell death: Recommendations of
the nomenclature committee on cell death 2018. Cell Death Differ.
25:486–541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Guerrero-Mauvecin J, Villar-Gomez N,
Rayego-Mateos S, Ramos AM, Ruiz-Ortega M, Ortiz A and Sanz AB:
Regulated necrosis role in inflammation and repair in acute kidney
injury. Front Immunol. 14:13249962023. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Annibaldi A and Meier P: Checkpoints in
TNF-Induced cell death: Implications in inflammation and cancer.
Trends Mol Med. 24:49–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Seo J, Nam YW, Kim S, Oh DB and Song J:
Necroptosis molecular mechanisms: Recent findings regarding novel
necroptosis regulators. Exp Mol Med. 53:1007–117. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Luedde T, Kaplowitz N and Schwabe RF: Cell
death and cell death responses in liver disease: Mechanisms and
clinical relevance. Gastroenterology. 147:765–83.e4. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Koike A, Hanatani M and Fujimori K:
Pan-caspase inhibitors induce necroptosis via ROS-mediated
activation of mixed lineage kinase domain-like protein and p38 in
classically activated macrophages. Exp Cell Res. 380:171–179. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Horvath C, Young M, Jarabicova I,
Kindernay L, Ferenczyova K, Ravingerova T, Lewis M and Suleiman MS:
Inhibition of cardiac RIP3 mitigates early reperfusion injury and
Calcium-induced mitochondrial swelling without altering necroptotic
signalling. Int J Mol Sci. 22:79832021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Oerlemans MI, Liu J, Arslan F, den Ouden
K, van Middelaar BJ, Doevendans PA and Sluijter JP: Inhibition of
RIP1-dependent necrosis prevents adverse cardiac remodeling after
myocardial ischemia-reperfusion in vivo. Basic Res Cardiol.
107:2702012. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Luo Y, Apaijai N, Liao S, Maneechote C,
Chunchai T, Arunsak B, Benjanuwattra J, Yanpiset P, Chattipakorn SC
and Chattipakorn N: Therapeutic potentials of cell death inhibitors
in rats with cardiac ischaemia/reperfusion injury. J Cell Mol Med.
26:2462–2476. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Guo R and Ren J: Alcohol dehydrogenase
accentuates ethanol-induced myocardial dysfunction and
mitochondrial damage in mice: Role of mitochondrial death pathway.
PLoS One. 5:e87572010. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Gao Y, Xu Y, Hua S, Zhou S and Wang K:
ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac
apoptosis and oxidative stress. Int J Clin Exp Med. 8:6794–6803.
2015.PubMed/NCBI
|
|
121
|
Liu M, Li H, Yang R, Ji D and Xia X:
GSK872 and necrostatin-1 protect retinal ganglion cells against
necroptosis through inhibition of RIP1/RIP3/MLKL pathway in
glutamate-induced retinal excitotoxic model of glaucoma. J
Neuroinflammation. 19:2622022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Shen C, Wang C, Han S, Wang Z, Dong Z,
Zhao X, Wang P, Zhu H, Sun X, Ma X, et al: Aldehyde dehydrogenase 2
deficiency negates chronic low-to-moderate alcohol
consumption-induced cardioprotecion possibly via ROS-dependent
apoptosis and RIP1/RIP3/MLKL-mediated necroptosis. Biochim Biophys
Acta Mol Basis Dis. 1863:1912–1918. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhai X, Wang W, Sun S, Han Y, Li J, Cao S,
Li R, Xu T, Yuan Q, Wang J, et al: 4-Hydroxy-2-nonenal promotes
cardiomyocyte necroptosis via stabilizing receptor-interacting
serine/threonine-protein kinase 1. Front Cell Dev Biol.
9:7217952021. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Fang T, Cao R, Wang W, Ye H, Shen L, Li Z,
Hu J and Gao Q: Alterations in necroptosis during ALDH2-mediated
protection against high glucose-induced H9c2 cardiac cell injury.
Mol Med Rep. 18:2807–2815. 2018.PubMed/NCBI
|
|
125
|
Zhang J, Wang R, Xie L, Ren H, Luo D, Yang
Y, Xie H, Shang Z and Liu C: Pharmacological activation of aldehyde
dehydrogenase 2 inhibits ferroptosis via SLC7A11/GPX4 axis to
reduce kidney stone formation. Eur J Pharmacol. 986:1771322025.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Chen J, Hu C, Lu X, Yang X, Zhu M, Ma X
and Yang Y: ALDH2 alleviates inflammation and facilitates
osteogenic differentiation of periodontal ligament stem cells in
periodontitis by blocking ferroptosis via activating Nrf2. Funct
Integr Genomics. 24:1842024. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Zhang Y, Yuan Z, Chai J, Zhu D, Miao X,
Zhou J and Gu X: ALDH2 ameliorates ethanol-induced gastric ulcer
through suppressing NLPR3 inflammasome activation and ferroptosis.
Arch Biochem Biophys. 743:1096212023. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Shan G, Bian Y, Yao G, Liang J, Shi H, Hu
Z, Zheng Z, Bi G, Fan H and Zhan C: Targeting ALDH2 to augment
platinum-based chemosensitivity through ferroptosis in lung
adenocarcinoma. Free Radic Biol Med. 224:310–324. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Zhu ZY, Liu YD, Gong Y, Jin W, Topchiy E,
Turdi S, Gao YF, Culver B, Wang SY, Ge W, et al: Mitochondrial
aldehyde dehydrogenase (ALDH2) rescues cardiac contractile
dysfunction in an APP/PS1 murine model of Alzheimer's disease via
inhibition of ACSL4-dependent ferroptosis. Acta Pharmacol Sin.
43:39–49. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Li W, Yin L, Sun X, Wu J, Dong Z, Hu K,
Sun A and Ge J: Alpha-lipoic acid protects against pressure
overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1
signaling. Cell Death Dis. 11:5992020. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Ma X, Luo Q, Zhu H, Liu X, Dong Z, Zhang
K, Zou Y, Wu J, Ge J and Sun A: Aldehyde dehydrogenase 2 activation
ameliorates CCl4-induced chronic liver fibrosis in mice by
up-regulating Nrf2/HO-1 antioxidant pathway. J Cell Mol Med.
22:3965–3978. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Tao Y, Huang X, Xie Y, Zhou X, He X, Tang
S, Liao M, Chen Y, Tan A, Chen Y, et al: Genome-wide association
and gene-environment interaction study identifies variants in ALDH2
associated with serum ferritin in a Chinese population. Gene.
685:196–201. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Chen CH, Budas GR, Churchill EN, Disatnik
MH, Hurley TD and Mochly-Rosen D: Activation of aldehyde
dehydrogenase-2 reduces ischemic damage to the heart. Science.
321:1493–1495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Beretta M, Gorren AC, Wenzl MV, Weis R,
Russwurm M, Koesling D, Schmidt K and Mayer B: Characterization of
the East Asian variant of aldehyde dehydrogenase-2: Bioactivation
of nitroglycerin and effects of Alda-1. J Biol Chem. 285:943–952.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Perez-Miller S, Younus H, Vanam R, Chen
CH, Mochly-Rosen D and Hurley TD: Alda-1 is an agonist and chemical
chaperone for the common human aldehyde dehydrogenase 2 variant.
Nat Struct Mol Biol. 17:159–1564. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Doorn JA, Hurley TD and Petersen DR:
Inhibition of human mitochondrial aldehyde dehydrogenase by
4-hydroxynon-2-enal and 4-oxonon-2-enal. Chem Res Toxicol.
19:102–110. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Budas GR, Disatnik MH and Mochly-Rosen D:
Aldehyde dehydrogenase 2 in cardiac protection: A new therapeutic
target? Trends Cardiovasc Med. 19:158–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Malyshev Y, Neuzil P, Petru J, Funasako M,
Hala P, Kopriva K, Schneider C, Achyutha A, Vanderper A, Musikantow
D, et al: Nitroglycerin to ameliorate coronary artery spasm during
focal Pulsed-Field ablation for atrial fibrillation. JACC Clin
Electrophysiol. 10:885–896. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Mollace V, Muscoli C, Dagostino C,
Giancotti LA, Gliozzi M, Sacco I, Visalli V, Gratteri S, Palma E,
Malara N, et al: The effect of peroxynitrite decomposition catalyst
MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates:
Role in nitrate tolerance. Pharmacol Res. 89:29–35. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Salvemini D, Pistelli A and Mollace V:
Release of nitric oxide from glyceryl trinitrate by captopril but
not enalaprilat: In vitro and in vivo studies. Br J Pharmacol.
109:430–436. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Munzel T and Daiber A: The potential of
aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular
disease. Expert Opin Ther Targets. 22:217–231. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Li Y, Zhang D, Jin W, Shao C, Yan P, Xu C,
Sheng H, Liu Y, Yu J, Xie Y, et al: Mitochondrial aldehyde
dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the
variation in efficacy of sublingual nitroglycerin. J Clin Invest.
116:506–511. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Nagano T, Ushijima K, Taga N, Takeuchi M,
Kawada MA, Aizawa K, Imai Y and Fujimura A: Influence of the
aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of
nitroglycerin in infants with congenital heart disease and
pulmonary arterial hypertension. Eur J Clin Pharmacol.
75:1361–1367. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Maiuolo J, Oppedisano F, Carresi C,
Gliozzi M, Musolino V, Macri R, Scarano F, Coppoletta A, Cardamone
A, Bosco F, et al: The generation of nitric oxide from aldehyde
Dehydrogenase-2: The role of dietary nitrates and their implication
in cardiovascular disease management. Int J Mol Sci. 23:154542022.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Marini E, Giorgis M, Leporati M, Rolando
B, Chegaev K, Lazzarato L, Bertinaria M, Vincenti M and Di Stilo A:
Multitarget antioxidant NO-donor organic nitrates: A novel approach
to overcome nitrates tolerance, an ex vivo study. Antioxidants
(Basel). 11:1662022. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Chen YR, Nie SD, Shan W, Jiang DJ, Shi RZ,
Zhou Z, Guo R, Zhang Z and Li YJ: Decrease in endogenous CGRP
release in nitroglycerin tolerance: Role of ALDH-2. Eur J
Pharmacol. 571:44–50. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Kim EJ, Kim SY, Lee JH, Kim JM, Kim JS,
Byun JI and Koo BN: Effect of isoflurane post-treatment on
tPA-exaggerated brain injury in a rat ischemic stroke model. Korean
J Anesthesiol. 68:281–286. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Zangrillo A, Lomivorotov VV, Pasyuga VV,
Belletti A, Gazivoda G, Monaco F, Nigro Neto C, Likhvantsev VV,
Bradic N, Lozovskiy A, et al: Effect of volatile anesthetics on
myocardial infarction after coronary artery surgery: A post hoc
analysis of a randomized trial. J Cardiothorac Vasc Anesth.
36:2454–2462. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Yuan J and Fu X: MicroRNA-21 mediates the
protective role of emulsified isoflurane against myocardial
ischemia/reperfusion injury in mice by targeting SPP1. Cell Signal.
86:1100862021. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Ku HC, Huang CW and Lee SY: Technical
refinement of a bilateral renal Ischemia-reperfusion mouse model
for acute kidney injury research. J Vis Exp. Nov 3–2023.doi:
10.3791/63957. View
Article : Google Scholar : PubMed/NCBI
|
|
151
|
Obeid PCI, Natalini CC and Howell GE:
Exposure to emulsified isoflurane and sevoflurane protects canine
primary hepatocytes against hypoxia-induced apoptosis. Am J Vet
Res. 1–8. 2023.doi: 10.2460/ajvr.23.08.0192 (Epub ahead of print).
PubMed/NCBI
|
|
152
|
Li H and Lang XE: Protein kinase C
signaling pathway involvement in cardioprotection during isoflurane
pretreatment. Mol Med Rep. 11:2683–2688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Cleveland JC Jr, Meldrum DR, Rowland RT,
Banerjee A and Harken AH: Adenosine preconditioning of human
myocardium is dependent upon the ATP-sensitive K+ channel. J Mol
Cell Cardiol. 29:175–182. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Zhao Z, Shi Q, Guo Q, Peng L, Li X, Rao L
and Li M: Remote ischemic preconditioning can extend the tolerance
to extended drug-coated balloon inflation time by reducing
myocardial damage during percutaneous coronary intervention. Int J
Cardiol. 353:3–8. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Amador A, Grande L, Marti J, Deulofeu R,
Miquel R, Sola A, Rodriguez-Laiz G, Ferrer J, Fondevila C, Charco
R, et al: Ischemic pre-conditioning in deceased donor liver
transplantation: A prospective randomized clinical trial. Am J
Transplant. 7:2180–2189. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Hardt J, Seyfried S, Brodrecht H, Khalil
L, Buttner S, Herrle F, Reissfelder C and Rahbari NN: Remote
ischemic preconditioning versus sham-control for prevention of
anastomotic leakage after resection for rectal cancer (RIPAL
trial): A pilot randomized controlled, triple-blinded monocenter
trial. Int J Colorectal Dis. 39:652024. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Ueta CB, Campos JC, Albuquerque RPE, Lima
VM, Disatnik MH, Sanchez AB, Chen CH, de Medeiros MHG, Yang W,
Mochly-Rosen D and Ferreira JCB: Cardioprotection induced by a
brief exposure to acetaldehyde: Role of aldehyde dehydrogenase 2.
Cardiovasc Res. 114:1006–1015. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Marino A and Levi R: Salvaging the
ischemic heart: Gi-coupled receptors in mast cells activate a
PKCepsilon/ALDH2 pathway providing Anti-RAS cardioprotection. Curr
Med Chem. 25:4416–4431. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Churchill EN, Disatnik MH and Mochly-Rosen
D: Time-dependent and ethanol-induced cardiac protection from
ischemia mediated by mitochondrial translocation of varepsilonPKC
and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol.
46:278–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Chen CH, Gray MO and Mochly-Rosen D:
Cardioprotection from ischemia by a brief exposure to physiological
levels of ethanol: Role of epsilon protein kinase C. Proc Natl Acad
Sci USA. 96:12784–12789. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Kang PF, Wu WJ, Tang Y, Xuan L, Guan SD,
Tang B, Zhang H, Gao Q and Wang HJ: Activation of ALDH2 with low
concentration of ethanol attenuates myocardial Ischemia/Reperfusion
injury in diabetes rat model. Oxid Med Cell Longev.
2016:61905042016. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Li D, Chen J, Ai Y, Gu X, Li L, Che D,
Jiang Z, Li L, Chen S, Huang H, et al: Estrogen-related hormones
induce apoptosis by stabilizing Schlafen-12 protein turnover. Mol
Cell. 75:1103–16.e9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Ji E, Jiao T, Shen Y, Xu Y, Sun Y, Cai Z,
Zhang Q and Li J: Molecular mechanism of HSF1-Upregulated ALDH2 by
PKC in ameliorating pressure overload-induced heart failure in
mice. Biomed Res Int. 2020:34816232020. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Wang S, Wang L, Qin X, Turdi S, Sun D,
Culver B, Reiter RJ, Wang X, Zhou H and Ren J: ALDH2 contributes to
melatonin-induced protection against APP/PS1 mutation-prompted
cardiac anomalies through cGAS-STING-TBK1-mediated regulation of
mitophagy. Signal Transduct Target Ther. 5:1192020. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Luo G, Huang B, Qiu X, Xiao L, Wang N, Gao
Q, Yang W and Hao L: Resveratrol attenuates excessive ethanol
exposure induced insulin resistance in rats via improving NAD+/NADH
ratio. Mol Nutr Food Res. 612017.doi: 10.1002/mnfr.201700087.
|
|
166
|
Zhang H, Xue L, Li B, Zhang Z and Tao S:
Vitamin D protects against alcohol-induced liver cell injury within
an NRF2-ALDH2 feedback loop. Mol Nutr Food Res. 63:e18010142019.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
He JD and Parker JD: The effect of vitamin
C on nitroglycerin-mediated vasodilation in individuals with and
without the aldehyde dehydrogenase 2 polymorphism. Br J Clin
Pharmacol. 89:2767–2774. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Rodriguez-Gutierrez G, Duthie GG, Wood S,
Morrice P, Nicol F, Reid M, Cantlay LL, Kelder T, Horgan GW,
Fernández-Bolaños Guzmán J and de Roos B: Alperujo extract,
hydroxytyrosol, and 3,4-dihydroxyphenylglycol are bioavailable and
have antioxidant properties in vitamin E-deficient rats-a
proteomics and network analysis approach. Mol Nutr Food Res.
56:1137–1147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Hosoi T, Yamaguchi R, Noji K, Matsuo S,
Baba S, Toyoda K, Suezawa T, Kayano T, Tanaka S and Ozawa K:
Flurbiprofen ameliorated obesity by attenuating leptin resistance
induced by endoplasmic reticulum stress. EMBO Mol Med. 6:335–346.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Balber AE: Concise review: Aldehyde
dehydrogenase bright stem and progenitor cell populations from
normal tissues: Characteristics, activities, and emerging uses in
regenerative medicine. Stem Cells. 29:570–575. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Perin EC, Silva GV, Zheng Y, Gahremanpour
A, Canales J, Patel D, Fernandes MR, Keller LH, Quan X, Coulter SA,
et al: Randomized, double-blind pilot study of transendocardial
injection of autologous aldehyde dehydrogenase-bright stem cells in
patients with ischemic heart failure. Am Heart J. 163:415–421.e1.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Perin EC, Murphy M, Cooke JP, Moye L,
Henry TD, Bettencourt J, Gahremanpour A, Leeper N, Anderson RD,
Hiatt WR, et al: Rationale and design for PACE: Patients with
intermittent claudication injected with ALDH bright cells. Am Heart
J. 168:667–673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Perin EC, Murphy MP, March KL, Bolli R,
Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD,
et al: Evaluation of cell therapy on exercise performance and limb
perfusion in peripheral artery disease: The CCTRN PACE trial
(Patients with intermittent claudication injected with ALDH bright
cells). Circulation. 135:1417–1428. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Sun X, Zhu H, Dong Z, Liu X, Ma X, Han S,
Lu F, Wang P, Qian S, Wang C, et al: Mitochondrial aldehyde
dehydrogenase-2 deficiency compromises therapeutic effect of ALDH
bright cell on peripheral ischemia. Redox Biol. 13:196–206. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Gao M, Monian P, Quadri N, Ramasamy R and
Jiang X: Glutaminolysis and transferrin regulate ferroptosis. Mol
Cell. 59:298–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Chan W, Taylor AJ, Ellims AH, Lefkovits L,
Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, et al:
Effect of iron chelation on myocardial infarct size and oxidative
stress in ST-elevation-myocardial infarction. Circ Cardiovasc
Interv. 5:270–278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Fang X, Wang H, Han D, Xie E, Yang X, Wei
J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for
protection against cardiomyopathy. Proc Natl Acad Sci USA.
116:2672–2680. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Li W, Feng G, Gauthier JM, Lokshina I,
Higashikubo R, Evans S, Kiertiburanakul S, Lee MP, Supparatpinyo K,
Zhang F, et al: Ferroptotic cell death and TLR4/Trif signaling
initiate neutrophil recruitment after heart transplantation. J Clin
Invest. 129:2293–2304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Li Y, Feng D, Wang Z, Zhao Y, Sun R, Tian
D, Liu D, Zhang F, Ning S, Yao J and Tian X: Ischemia-induced ACSL4
activation contributes to ferroptosis-mediated tissue injury in
intestinal ischemia/reperfusion. Cell Death Differ. 26:2284–2299.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Liu B, Zhao C, Li H, Chen X, Ding Y and Xu
S: Puerarin protects against heart failure induced by pressure
overload through mitigation of ferroptosis. Biochem Biophys Res
Commun. 497:233–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Yu W, An S, Shao T, Xu H, Chen H, Ning J,
Zhou Y and Chai X: Active compounds of herbs ameliorate impaired
cognition in APP/PS1 mouse model of Alzheimer's disease. Aging
(Albany NY). 11:11186–11201. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Eleftheriadis T, Pissas G, Filippidis G,
Liakopoulos V and Stefanidis I: Reoxygenation induces reactive
oxygen species production and ferroptosis in renal tubular
epithelial cells by activating aryl hydrocarbon receptor.
Mol Med Rep. 23:412021.PubMed/NCBI
|
|
183
|
Chen K, Xu Z, Liu Y, Wang Z, Li Y, Xu X,
Chen C, Xia T, Liao Q, Yao Y, et al: Irisin protects mitochondria
function during pulmonary ischemia/reperfusion injury. Sci Transl
Med. 9:eaao62982017. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Lu J, Xu F and Lu H: LncRNA PVT1 regulates
ferroptosis through miR-214-mediated TFR1 and p53. Life Sci.
260:1183052020. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Stamenkovic A, O'Hara KA, Nelson DC,
Maddaford TG, Edel AL, Maddaford G, Dibrov E, Aghanoori M,
Kirshenbaum LA, Fernyhough P, et al: Oxidized phosphatidylcholines
trigger ferroptosis in cardiomyocytes during ischemia-reperfusion
injury. Am J Physiol Heart Circ Physiol. 320:H1170–H1184. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Tuo QZ, Lei P, Jackman KA, Li XL, Xiong H,
Li XL, Liuyang ZY, Roisman L, Zhang ST, Ayton S, et al:
Tau-mediated iron export prevents ferroptotic damage after ischemic
stroke. Mol Psychiatry. 22:1520–1530. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Wu S, Yang J, Sun G, Hu J, Zhang Q, Cai J,
Yuan D, Li H, Hei Z and Yao W: Macrophage extracellular traps
aggravate iron overload-related liver ischaemia/reperfusion injury.
Br J Pharmacol. 178:3783–3796. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Xu Y, Li X, Cheng Y, Yang M and Wang R:
Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary
ischemia-reperfusion. FASEB J. 34:16262–16275. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Yamada N, Karasawa T, Wakiya T, Sadatomo
A, Ito H, Kamata R, Watanabe S, Komada T, Kimura H, Sanada Y, et
al: Iron overload as a risk factor for hepatic Ischemia-Reperfusion
injury in liver transplantation: Potential role of ferroptosis. Am
J Transplant. 20:1606–1618. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Zhou L, Xue X, Hou Q and Dai C: Targeting
ferroptosis attenuates interstitial inflammation and kidney
fibrosis. Kidney Dis (Basel). 8:57–71. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Tu H, Zhou YJ, Tang LJ, Xiong XM, Zhang
XJ, Ali Sheikh MS, Zhang JJ, Luo XJ, Yuan C and Peng J: Combination
of ponatinib with deferoxamine synergistically mitigates ischemic
heart injury via simultaneous prevention of necroptosis and
ferroptosis. Eur J Pharmacol. 898:1739992021. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Shi Y, Han L, Zhang X, Xie L, Pan P and
Chen F: Selenium alleviates cerebral Ischemia/reperfusion injury by
regulating oxidative stress, mitochondrial fusion and ferroptosis.
Neurochem Res. 47:2992–3002. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Lv Z, Wang F, Zhang X, Zhang X, Zhang J
and Liu R: Etomidate attenuates the ferroptosis in myocardial
Ischemia/Reperfusion rat model via Nrf2/HO-1 pathway. Shock.
56:440–449. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Yang J, Sun X, Huang N, Li P, He J, Jiang
L, Zhang X, Han S and Xin H: Entacapone alleviates acute kidney
injury by inhibiting ferroptosis. FASEB J. 36:e223992022.
View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Chen Y, He W, Wei H, Chang C, Yang L, Meng
J, Long T, Xu Q and Zhang C: Srs11-92, a ferrostatin-1 analog,
improves oxidative stress and neuroinflammation via Nrf2 signal
following cerebral ischemia/reperfusion injury. CNS Neurosci Ther.
29:1667–1677. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Li C and Liu Y: Puerarin reduces cell
damage from cerebral ischemia-reperfusion by inhibiting
ferroptosis. Biochem Biophys Res Commun. 693:1493242024. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Ding Y, Li W, Peng S, Zhou G, Chen S, Wei
Y, Xu J, Gu H, Li J, Liu S and Liu B: Puerarin protects against
myocardial Ischemia/Reperfusion injury by inhibiting ferroptosis.
Biol Pharm Bull. 46:524–532. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Guan X, Li X, Yang X, Yan J, Shi P, Ba L,
Cao Y and Wang P: The neuroprotective effects of carvacrol on
ischemia/reperfusion-induced hippocampal neuronal impairment by
ferroptosis mitigation. Life Sci. 235:1167952019. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Fu C, Wu Y, Liu S, Luo C, Lu Y, Liu M,
Wang L, Zhang Y and Liu X: Rehmannioside A improves cognitive
impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2
and SLC7A11/GPX4 signaling pathway after ischemia. J
Ethnopharmacol. 289:1150212022. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Yang T, Liu H, Yang C, Mo H, Wang X, Song
X, Jiang L, Deng P, Chen R, Wu P, et al: Galangin attenuates
myocardial ischemic Reperfusion-Induced ferroptosis by targeting
Nrf2/Gpx4 signaling pathway. Drug Des Devel Ther. 17:2495–2511.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Guo H, Zhu L, Tang P, Chen D, Li Y, Li J
and Bao C: Carthamin yellow improves cerebral ischemia-reperfusion
injury by attenuating inflammation and ferroptosis in rats. Int J
Mol Med. 47:522021. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Yuan Y, Zhai Y, Chen J, Xu X and Wang H:
Kaempferol ameliorates Oxygen-glucose
deprivation/reoxygenation-induced neuronal ferroptosis by
activating Nrf2/SLC7A11/GPX4 Axis. Biomolecules. 11:9232021.
View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Lin JH, Yang KT, Ting PC, Luo YP, Lin DJ,
Wang YS and Chang JC: Gossypol acetic acid attenuates cardiac
ischemia/reperfusion injury in rats via an antiferroptotic
mechanism. Biomolecules. 11:16672021. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Du YW, Li XK, Wang TT, Zhou L, Li HR, Feng
L, Ma H and Liu HB: Cyanidin-3-glucoside inhibits ferroptosis in
renal tubular cells after ischemia/reperfusion injury via the AMPK
pathway. Mol Med. 29:422023. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X,
Huang Z, Lin M, Wu H and Xu D: Naringenin alleviates myocardial
ischemia/reperfusion injury by regulating the nuclear
factor-erythroid factor 2-related factor 2 (Nrf2)/System
xc-/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
Bioengineered. 12:10924–10934. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Li T, Tan Y, Ouyang S, He J and Liu L:
Resveratrol protects against myocardial ischemia-reperfusion injury
via attenuating ferroptosis. Gene. 808:1459682022. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Zhu H, Huang J, Chen Y, Li X, Wen J, Tian
M, Ren J, Zhou L and Yang Q: Resveratrol pretreatment protects
neurons from oxygen-glucose deprivation/reoxygenation and ischemic
injury through inhibiting ferroptosis. Biosci Biotechnol Biochem.
86:704–716. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Wang X, Shen T, Lian J, Deng K, Qu C, Li
E, Li G, Ren Y, Wang Z, Jiang Z, et al: Resveratrol reduces
ROS-induced ferroptosis by activating SIRT3 and compensating the
GSH/GPX4 pathway. Mol Med. 29:1372023. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Zhang J, Bi J, Ren Y, Du Z, Li T, Wang T,
Zhang L, Wang M, Wei S, Lv Y and Wu R: Involvement of GPX4 in
irisin's protection against ischemia reperfusion-induced acute
kidney injury. J Cell Physiol. 236:931–945. 2021. View Article : Google Scholar : PubMed/NCBI
|
